Our clients’ success depends not only on their scientific discoveries, but also on their ability to protect and progress them into commercial products. Arnold & Porter’s Life Sciences practice has a global reputation for advising life sciences companies at every stage of the product life cycle, from proof of concept and pre-clinical and clinical trials, through approval and launch, to post-market promotion, pharmacovigilance and market access.
Our team’s renowned industry knowledge and experience underpins the quality of our advice where overlapping issues require integrated specialist support. Our multidisciplinary team advises on structuring complex drug development and licensing deals, negotiating product or company acquisitions, maximising the protection of intellectual property and regulatory rights, minimizing exposure to product liability, resolving complex biotech disputes, and defending high-stakes enforcement investigations. The business of life sciences companies, and the development and commercialisation of healthcare technologies, biotech, medicinal products, cosmetics and foods, is deeply ingrained in our practice.
What others say:
“Their reputation is completely justified. They are top of the tree.”
“I would recommend the team to anyone doing drug development work. They are just superb.”
—Chambers UK (2017)